Prime Movers Lab LLC Vaxxinity, Inc. Transaction History

Prime Movers Lab LLC

  • $13.5 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.64 - $2.48 $401,862 - $607,694
-245,038 Reduced 1.37%
17,603,276 $31.4 Million
Q2 2022

Aug 15, 2022
SELL
$1.55 - $6.95 $277,450 - $1.24 Million
-179,000 Reduced 0.99%
17,848,314 $25.2 Million
Q4 2021

Mar 10, 2022
BUY
$5.55 - $18.46 $100 Million - $333 Million
18,027,314 New
18,027,314 $91 Million

Others Institutions Holding VAXX

# of Institutions
7
Shares Held
287K
Call Options Held
0
Put Options Held
0
View Full List

About Vaxxinity, Inc.

VAXX Quotes by TradingView
  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Market Cap $1.12M
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Prime Movers Lab LLC Portfolio

Follow Prime Movers Lab LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Movers Lab LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Movers Lab LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email